These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 8325692

  • 1. Prenatal vitamin K for low birth weight infants.
    Lazarchick J.
    Int J Artif Organs; 1993 Apr; 16(4):175-6. PubMed ID: 8325692
    [No Abstract] [Full Text] [Related]

  • 2. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants.
    Kazzi NJ, Ilagan NB, Liang KC, Kazzi GM, Poland RL, Grietsell LA, Fujii Y, Brans YW.
    Pediatrics; 1989 Dec; 84(6):1045-50. PubMed ID: 2587133
    [Abstract] [Full Text] [Related]

  • 3. Maternally administered antenatal vitamin K1: effect on neonatal prothrombin activity, partial thromboplastin time, and intraventricular hemorrhage.
    Pomerance JJ, Teal JG, Gogolok JF, Brown S, Stewart ME.
    Obstet Gynecol; 1987 Aug; 70(2):235-41. PubMed ID: 3601288
    [Abstract] [Full Text] [Related]

  • 4. Antenatal vitamin K therapy of the low-birth-weight infant.
    Dickson RC, Stubbs TM, Lazarchick J.
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):85-9. PubMed ID: 8296850
    [Abstract] [Full Text] [Related]

  • 5. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.
    Liu J, Wang Q, Gao F, He JW, Zhao JH.
    J Perinat Med; 2006 Jan; 34(2):173-6. PubMed ID: 16519625
    [Abstract] [Full Text] [Related]

  • 6. Intraventricular hemorrhage in preterm infants: coagulation perspectives.
    Kuperman AA, Kenet G, Papadakis E, Brenner B.
    Semin Thromb Hemost; 2011 Oct; 37(7):730-6. PubMed ID: 22187395
    [Abstract] [Full Text] [Related]

  • 7. [Level of vitamin K-dependent coagulation factors in premature infants and the influence of maternal antenatal administration of vitamin K1 on their activity].
    Liu J, Wang Q, Chen YH, Qin GL, Zhao JH, Zhu LC.
    Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):908-10. PubMed ID: 16412352
    [Abstract] [Full Text] [Related]

  • 8. Maternal-fetal transport of vitamin K1 and its effects on coagulation in premature infants.
    Yang YM, Simon N, Maertens P, Brigham S, Liu P.
    J Pediatr; 1989 Dec; 115(6):1009-13. PubMed ID: 2585215
    [Abstract] [Full Text] [Related]

  • 9. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized, double-blind, placebo-controlled trial.
    De Lia JE, Billman D.
    Obstet Gynecol; 1994 Jun; 83(6):1067-9. PubMed ID: 8190426
    [No Abstract] [Full Text] [Related]

  • 10. Current concepts and controversies in the use of vitamin K.
    Thorp JA, Gaston L, Caspers DR, Pal ML.
    Drugs; 1995 Mar; 49(3):376-87. PubMed ID: 7774512
    [Abstract] [Full Text] [Related]

  • 11. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation.
    Liu J, Wang Q, Zhao JH, Chen YH, Qin GL.
    J Trop Pediatr; 2006 Oct; 52(5):355-9. PubMed ID: 16751657
    [Abstract] [Full Text] [Related]

  • 12. Antepartum vitamin K and phenobarbital for preventing intraventricular hemorrhage in the premature newborn: a randomized, double-blind, placebo-controlled trial.
    Thorp JA, Parriott J, Ferrette-Smith D, Meyer BA, Cohen GR, Johnson J.
    Obstet Gynecol; 1994 Jan; 83(1):70-6. PubMed ID: 8272312
    [Abstract] [Full Text] [Related]

  • 13. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
    Thorp JA, Caspers DR, Cohen GR, Zucker ML, Strope BD, McKenzie DR.
    Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
    [Abstract] [Full Text] [Related]

  • 14. Intra-ventricular hemorrhage and method of delivery of very low birth weight infants.
    Greisen G, Petersen MB.
    J Perinat Med; 1983 Dec; 11(2):67-73. PubMed ID: 6343580
    [No Abstract] [Full Text] [Related]

  • 15. Prevention of cerebral hemorrhage in preterm infants.
    Wigglesworth JS.
    Lancet; 1979 Aug 04; 2(8136):256. PubMed ID: 89373
    [No Abstract] [Full Text] [Related]

  • 16. [Thrombotest in sick premature infants].
    Waltl H, Pistoja F, Kurz R.
    Padiatr Padol; 1973 Aug 04; 8(3):284-90. PubMed ID: 4715037
    [No Abstract] [Full Text] [Related]

  • 17. Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation.
    Thorp JA, Ferrette-Smith D, Gaston LA, Johnson J, Yeast JD, Meyer B.
    Obstet Gynecol; 1995 Jul 04; 86(1):1-8. PubMed ID: 7784000
    [Abstract] [Full Text] [Related]

  • 18. Questions on the vitamin E study.
    Jansen RD.
    Pediatrics; 1985 Aug 04; 76(2):326-9. PubMed ID: 3895153
    [No Abstract] [Full Text] [Related]

  • 19. The use of antenatal vitamin K in the prevention of early neonatal intraventricular hemorrhage.
    Morales WJ, Angel JL, O'Brien WF, Knuppel RA, Marsalisi F.
    Am J Obstet Gynecol; 1988 Sep 04; 159(3):774-9. PubMed ID: 3421279
    [Abstract] [Full Text] [Related]

  • 20. Maternal prophylactic vitamin K treatment and response in cord plasma of coagulation factor (II, VII, X) activity.
    Felding C, Jul E.
    Pediatr Hematol Oncol; 1988 Sep 04; 5(1):77-80. PubMed ID: 3152955
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.